Belgium Urges EU to Ready Trade Bazooka Over US Pharma Warnings

Belgium’s Deputy Prime Minister Frank Vandenbroucke has called on the European Union to prepare its heaviest commercial countermeasure—the bloc’s so-called "trade bazooka"—against the United States over threats directed at the pharmaceutical industry. Vandenbroucke warned that transatlantic pressure could trigger an extreme spike in European medicine prices or even prompt manufacturers to pull essential therapies from the EU market altogether.

For everyday citizens, the spat touches the medicine cabinet rather than dry tariff schedules. Healthcare systems across the continent are already strained by high costs and periodic drug supply disruptions. If pharmaceutical products become leverage in a wider geopolitical standoff, national health services could be forced to choose between paying exorbitant premiums to foreign suppliers or watching treatments disappear from clinic shelves.

In the jargon-heavy corridors of the EU quarter, the "trade bazooka" is the shorthand moniker for the bloc’s anti-coercion mechanism—a legal instrument designed to allow Brussels to retaliate swiftly against foreign powers that use economic pressure to dictate European policy. Normally, brandishing the trade arsenal is treated with the institutional equivalent of nuclear launch discipline: discussed in quiet murmurs behind closed doors so as not to alarm financial markets. A national deputy prime minister publicly recommending that Brussels point the weapon directly at Washington reflects genuine alarm over pharmaceutical supply chains. The European Commission holds the exclusive mandate to manage the EU’s joint trade policy, meaning national capitals must convince Berlaymont trade officials to take the plunge rather than firing commercial broadsides on their own.

Vandenbroucke’s demand shifts the conversation to the Council of the EU, where national ministers will weigh whether to escalate the dispute. Activating formal countermeasures is an elaborate bureaucratic dance: the European Commission must first assess whether the American posture constitutes unlawful economic coercion, followed by consultations among member states before any retaliatory trade measures can be enacted.